[1]
B. Welk, J. Reid, M. Ordon, J. Campbell, and S. Dixon, “Do 5 alpha reductase inhibitors decrease the risk of recurrent gross hematuria in patients who have had a transurethral prostatectomy?”, CUAJ, vol. 15, no. 6, pp. 214–6, Jan. 2021.